Bioanalysis and Bioanalysis Zone unveil the 6th edition of The Bioanalysis Glossary
[FOR IMMEDIATE RELEASE]
January 15, 2026
The Bioanalysis journal and Bioanalysis Zone team proudly announce the release of the 6th edition of The Bioanalysis Glossary, a must-have reference tool for scientists engaged in bioanalysis and related fields. This latest edition builds upon the success of its predecessor, featuring new terms and an updated section encompassing commonly used equations by bioanalysts across the industry.
“Since its creation, the Bioanalysis Glossary’s primary objective has been to facilitate the standardization of terminology used within the bioanalytical community, within and between companies, universities and individuals. In this increasingly globalized field, it has become necessary for scientists to speak the same bioanalytical language,” commented Jack Lodge, Journal Development Editor of Bioanalysis.
A valuable resource for those in the field of bioanalysis, The Bioanalysis Glossary aims to keep you up-to-date on the latest terminology and equations within the bioanalytical space. To ensure the utmost accuracy and comprehensiveness, we have worked closely with 15 prominent bioanalytical experts to provide a thorough update, reflecting the dynamic and constantly evolving nature of bioanalysis.
The Bioanalysis and Bioanalysis Zone team are very much committed to ensuring we keep moving with this progressive field and stay reflective of emerging novel techniques in bioanalysis. This updated edition includes over 30 new terms and a section of commonly used equations by bioanalysts across the field.
“Another defining moment in bioanalytical history. I hope that coming to terms with this new edition of the Bioanalysis Glossary will be meaningful to us all,” commented Robert MacNeill, Scientific Director at Bristol Myers Squibb (NJ, USA).
We would like to extend our gratitude to the members of the Glossary Editorial Panel for their invaluable assistance, advice and guidance, as well as to our Sponsors, Alturas Analytics, Celerion, KCAS Bio and WuXi AppTec, whose generous support has made this edition possible. Additionally, we would like to thank the Bioanalysis and Bioanalysis Zone readers, contributors and Editorial Board members for their continued support. As we move forward, we remain committed to updating this glossary with relevant new content and timely amendments to ensure the accuracy and relevance of every definition.
You can download a copy of the latest edition here:
About Bioanalysis
Bioanalysis is a hybrid open-access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
About Bioanalysis Zone
Our mission is to advance the field of bioanalysis by increasing subject understanding and sharing of knowledge across barriers to unite the bioanalytical community.
Bioanalysis Zone provides bioanalysts with a range of resources, including: the latest bioanalytical news; articles from Bioanalysis; exclusive interviews and commentaries from opinion leaders working within academia and the pharmaceutical industry; informative webinars; Spotlights focusing on bioanalytical ‘hot topics’; a business directory; and annual awards to show recognition of outstanding achievements in the field.
Since launching in 2011, Bioanalysis Zone has attracted over 30,000 active members from the global bioanalytical community, representing the pharmaceutical, biotech and CRO industries, along with academia and healthcare. Each month, thousands of members visit the site to read industry news, original research, exclusive interviews, webinars and commentaries. Join the Bioanalysis Zone X and LinkedIn group for updates.
For media inquiries, please contact: [email protected]
About Taylor & Francis
Taylor & Francis supports diverse communities of experts, researchers and knowledge makers around the world to accelerate and maximize the impact of their work. We are a leader in our field, publish across all disciplines and have one of the largest Humanities and Social Sciences portfolios. Our expertise, built on an academic publishing heritage of over 200 years, advances trusted knowledge that fosters human progress.
Our 2,500+ people, based in a global network of offices in more than 15 countries, use their skills and the latest technology to curate, validate and share impactful advanced, emergent and applied knowledge. Under the Taylor & Francis, Routledge and F1000 imprints we publish 2,700 journals, 8,000 new books each year and partner with more than 700 scholarly societies.
Taylor & Francis is proud to be a Global Certified Accessible™ publisher and our operations and all our print publications are certified CarbonNeutral®.
